Towers GJ - Search Results

1

In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix.

Datir R, Kemp S, El Bouzidi K, Mlchocova P, Goldstein R, Breuer J, Towers GJ, Jolly C, Quiñones-Mateu ME, Dakum PS, Ndembi N, Gupta RK. Datir R, et al. Among authors: towers gj. mBio. 2020 Nov 3;11(6):e02036-20. doi: 10.1128/mBio.02036-20. mBio. 2020. PMID: 33144375 Free PMC article.

2

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, Towers GJ. Gupta RK, et al. Among authors: towers gj. PLoS Pathog. 2009 May;5(5):e1000443. doi: 10.1371/journal.ppat.1000443. Epub 2009 May 22. PLoS Pathog. 2009. PMID: 19461879 Free PMC article.

3

Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1.

Parry CM, Kohli A, Boinett CJ, Towers GJ, McCormick AL, Pillay D. Parry CM, et al. Among authors: towers gj. J Virol. 2009 Sep;83(18):9094-101. doi: 10.1128/JVI.02356-08. Epub 2009 Jul 8. J Virol. 2009. PMID: 19587031 Free PMC article.

4

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.

Gupta RK, Mlcochova P, Pelchen-Matthews A, Petit SJ, Mattiuzzo G, Pillay D, Takeuchi Y, Marsh M, Towers GJ. Gupta RK, et al. Among authors: towers gj. Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20889-94. doi: 10.1073/pnas.0907075106. Epub 2009 Oct 28. Proc Natl Acad Sci U S A. 2009. PMID: 19864625 Free PMC article.

5

A tail of Tetherin: how pandemic HIV-1 conquered the world.

Gupta RK, Towers GJ. Gupta RK, et al. Among authors: towers gj. Cell Host Microbe. 2009 Nov 19;6(5):393-5. doi: 10.1016/j.chom.2009.11.002. Cell Host Microbe. 2009. PMID: 19917491 Free PMC article.

6

Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays.

Gupta RK, Kohli A, McCormick AL, Towers GJ, Pillay D, Parry CM. Gupta RK, et al. Among authors: towers gj. AIDS. 2010 Jul 17;24(11):1651-5. doi: 10.1097/qad.0b013e3283398216. AIDS. 2010. PMID: 20597164 Free PMC article.

7

Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.

McCormick AL, Parry CM, Crombe A, Goodall RL, Gupta RK, Kaleebu P, Kityo C, Chirara M, Towers GJ, Pillay D. McCormick AL, et al. Among authors: towers gj. Antimicrob Agents Chemother. 2011 Apr;55(4):1806-9. doi: 10.1128/AAC.01197-10. Epub 2011 Jan 31. Antimicrob Agents Chemother. 2011. PMID: 21282419 Free PMC article.

8

Ultra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membrane.

Gupta RK, Towers GJ. Gupta RK, et al. Among authors: towers gj. Viruses. 2010 Apr;2(4):987-994. doi: 10.3390/v2040987. Epub 2010 Apr 12. Viruses. 2010. PMID: 21994665 Free PMC article.

9

HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.

Sauter D, Hué S, Petit SJ, Plantier JC, Towers GJ, Kirchhoff F, Gupta RK. Sauter D, et al. Among authors: towers gj. Retrovirology. 2011 Dec 15;8:103. doi: 10.1186/1742-4690-8-103. Retrovirology. 2011. PMID: 22171785 Free PMC article.

10

Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages.

Mlcochova P, Watters SA, Towers GJ, Noursadeghi M, Gupta RK. Mlcochova P, et al. Among authors: towers gj. Retrovirology. 2014 Mar 21;11:25. doi: 10.1186/1742-4690-11-25. Retrovirology. 2014. PMID: 24656066 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters